Stocks and Investing Stocks and Investing
Thu, November 3, 2016

Andrew Peters Initiated (BMRN) at Strong Buy on, Nov 3rd, 2016


Published on 2024-10-25 19:10:55 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy on, Nov 3rd, 2016.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Friday, August 5th, 2016
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $125 on, Friday, August 5th, 2016